Targeting EZH2 for cancer therapy: progress and perspective.
about
MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2.Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis.Polycomb Repressive Complex 2: Emerging Roles in the Central Nervous System.Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer
P2860
Targeting EZH2 for cancer therapy: progress and perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting EZH2 for cancer therapy: progress and perspective.
@en
Targeting EZH2 for cancer therapy: progress and perspective.
@nl
type
label
Targeting EZH2 for cancer therapy: progress and perspective.
@en
Targeting EZH2 for cancer therapy: progress and perspective.
@nl
prefLabel
Targeting EZH2 for cancer therapy: progress and perspective.
@en
Targeting EZH2 for cancer therapy: progress and perspective.
@nl
P2860
P921
P1476
Targeting EZH2 for cancer therapy: progress and perspective
@en
P2093
Chi Han Li
P2860
P304
P356
10.2174/1389203716666150409100233
P5008
P577
2015-01-01T00:00:00Z